PETS (PetMed Express) Moat Score: 5/10 (As of Jun. 27, 2026)


PETS PetMed Express Inc PETS
56 GF Score
Price $1.76
GF Value $2.87
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PetMed Express Moat Score?

PetMed Express PETS -0.56% 56 Moat Score is 5 as of Jun. 27, 2026. GuruFocus rates PETS with a GF Score™ of 56/100 and a GF Value™ of $2.87 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 681 Healthcare Providers & Services companies, PetMed Express ranks better than 96.04% on this metric.

PetMed Express has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

PetMed Express has Narrow Moat: PetMed Express Inc has a solid narrow moat due to its established brand in the pet medication market and customer loyalty. The company benefits from some economies of scale and a strong distribution network, but faces competition from larger retailers, limiting its moat strength.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes PetMed Express might have Narrow Moat - Solid narrow moat.

PetMed Express  (NAS:PETS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

PetMed Express Moat Score Related Terms

PETS vs BHIC, SHFH, SCNX: Moat Score Comparison

For the Pharmaceutical Retailers subindustry, PetMed Express's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PetMed Express Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Moat Score distribution charts can be found below:

* The bar in red indicates where PetMed Express's Moat Score falls into.


PETS
56GF Score
PetMed Express Inc PETS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
PetMed Express (PETS) has a Moat Score of 5 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, PetMed Express ranks #27 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is PetMed Express' Moat Score too high?
PetMed Express' current Moat Score is 5. Based on the distribution chart, PetMed Express ranks #27 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PetMed Express has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' Moat Score compare to BHIC and SHFH?
According to the Healthcare Providers & Services industry distribution chart, PetMed Express ranks #27 out of 681 companies for Moat Score. This places PetMed Express in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. PetMed Express's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (PETS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.87, compared to a current price of $1.76 — trading 38.7% below its estimated fair value. The current Moat Score is 5. PetMed Express' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For PetMed Express (PETS), the current Moat Score is 5 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PetMed Express (PETS) Overvalued in 2026?

Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued. The current stock price of $1.76 is trading 38.7% below its estimated GF Value™ of $2.87. GuruFocus considers PetMed Express to be Possible Value Trap.

Key valuation signals for PETS:

  • Moat Score: 5
  • GF Value™: $2.87 vs. price of $1.76 (38.7% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PetMed Express Business Description

Address 420 South Congress Avenue, Suite 100, Delray Beach, FL, USA, 33445
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score

Get the complete analysis for PETS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.76
Price
$2.87
GF Value